Free Trial

genedrive (GDR) Competitors

genedrive logo
GBX 2.40
0.00 (0.00%)
(As of 11/1/2024 ET)

GDR vs. AGL, YGEN, ABDX, VRCI, PRM, GENI, IDHC, LLAI, DMTR, and LLA

Should you be buying genedrive stock or one of its competitors? The main competitors of genedrive include ANGLE (AGL), Yourgene Health (YGEN), Abingdon Health (ABDX), Verici Dx (VRCI), Proteome Sciences (PRM), GENinCode (GENI), Integrated Diagnostics (IDHC), LungLife AI (LLAI), Deepmatter Group (DMTR), and LLA.L,0P0001T9GN,0 (LLA). These companies are all part of the "diagnostics & research" industry.

genedrive vs.

ANGLE (LON:AGL) and genedrive (LON:GDR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk, community ranking and institutional ownership.

18.8% of ANGLE shares are owned by institutional investors. Comparatively, 0.3% of genedrive shares are owned by institutional investors. 16.2% of ANGLE shares are owned by company insiders. Comparatively, 14.8% of genedrive shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ANGLE currently has a consensus price target of GBX 70, indicating a potential upside of 803.23%. Given ANGLE's higher possible upside, equities research analysts plainly believe ANGLE is more favorable than genedrive.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ANGLE
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
genedrive
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

genedrive received 60 more outperform votes than ANGLE when rated by MarketBeat users. Likewise, 72.67% of users gave genedrive an outperform vote while only 62.33% of users gave ANGLE an outperform vote.

CompanyUnderperformOutperform
ANGLEOutperform Votes
182
62.33%
Underperform Votes
110
37.67%
genedriveOutperform Votes
242
72.67%
Underperform Votes
91
27.33%

ANGLE has a beta of 0.22, suggesting that its share price is 78% less volatile than the S&P 500. Comparatively, genedrive has a beta of -0.04, suggesting that its share price is 104% less volatile than the S&P 500.

ANGLE's return on equity of -63.75% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
ANGLEN/A -63.75% -29.89%
genedrive N/A -201.53%-74.09%

In the previous week, ANGLE's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.

Company Overall Sentiment
ANGLE Neutral
genedrive Neutral

genedrive has lower revenue, but higher earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ANGLE£2.02M12.37-£18.03M-£0.07-110.71
genedrive£49K266.03-£5M-£0.04-60.00

Summary

ANGLE beats genedrive on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GDR vs. The Competition

MetricgenedriveDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£13.04M£17.51M£5.40B£1.59B
Dividend Yield1.57%6.10%5.15%10.99%
P/E Ratio-60.002.18113.761,747.90
Price / Sales266.032,474.421,483.04231,381.08
Price / Cash2.004.6039.7136.00
Price / Book2.402.764.662.89
Net Income-£5M£59.41M£119.06M£144.83M
7 Day Performance9.09%-1.47%0.79%0.11%
1 Month Performance23.08%-7.57%5.65%-0.11%
1 Year Performance-70.91%18.67%36.80%15.34%

genedrive Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GDR
genedrive
N/AGBX 2.40
flat
N/A-71.0%£13.04M£49,000.00-60.0043News Coverage
Gap Up
AGL
ANGLE
1.647 of 5 stars
GBX 7.53
+3.8%
GBX 70
+830.2%
-33.8%£24.27M£2.02M-107.50650
YGEN
Yourgene Health
N/AGBX 0.52
flat
N/AN/A£16.43M£29.67M-51.50253
ABDX
Abingdon Health
N/AGBX 8.50
+3.0%
N/A-21.2%£16.11M£6.13M-899.0084Gap Up
VRCI
Verici Dx
N/AGBX 3.38
-3.6%
N/A-49.8%£8.19M£4.33M-168.7519Negative News
PRM
Proteome Sciences
N/AGBX 2.62
-6.9%
N/A-55.8%£7.72M£4.04M-261.60240Gap Down
GENI
GENinCode
N/AGBX 4
-2.4%
N/A-46.8%£7.08M£2.60M-80.042,300Gap Down
IDHC
Integrated Diagnostics
N/AGBX 0.52
+5.1%
N/A+37.8%£3.02M£4.75B17.336,692Gap Down
LLAI
LungLife AI
N/AGBX 9
-7.7%
N/A-91.0%£2.76M£98,566.00-69.2315Gap Down
DMTR
Deepmatter Group
N/AGBX 0.03
+22.2%
N/A+0.0%£1.33M£1.04M-0.11N/AGap Down
LLA
LLA.L,0P0001T9GN,0
N/AGBX 15
-25.0%
N/AN/A£0.00N/A-125.0015Gap Down
High Trading Volume

Related Companies and Tools


This page (LON:GDR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners